SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-18-000028
Filing Date
2018-06-22
Accepted
2018-06-22 16:18:12
Documents
1
Period of Report
2018-06-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3523
  Complete submission text file 0001735276-18-000028.txt   4942
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CARDINAL HEALTH PARTNERS 221 NASSAU STREET PRINCETON NJ 08542
Business Address
CLARKE JOHN K (Reporting) CIK: 0001219015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 18914732